Leveraging decades of expertise in ophthalmology clinical research, our dedicated specialists navigate the complexities of ocular drug and device development with precision, innovation, and a patient-centered approach to ensure the success of your trial.
TFS specializes in ophthalmology clinical trials, providing comprehensive support to navigate regulatory complexities, imaging requirements, and patient recruitment challenges unique to this field. Our cross-functional teams, spanning retinal diseases, corneal disorders, glaucoma, ocular inflammation, and ophthalmic rare diseases, bring extensive therapeutic expertise with global regulatory knowledge to accelerate the development of vision-saving treatments worldwide.
With a proven track record in ophthalmology drug and device development, we empower sponsors to streamline trial operations, enhance patient engagement, and ensure regulatory compliance across different regions. Whether conducting gene therapy trials for inherited retinal diseases, targeted therapies for glaucoma, or ophthalmic device studies, our full-service ophthalmology CRO solutions ensure efficient execution at every stage.
Ready to shape the future of ophthalmology clinical research? Connect with our ophthalmology clinical trial experts.
With nearly 30 years of experience and over 70 ophthalmology clinical trials completed, TFS is a trusted partner in ophthalmology drug and device development. Our team ensures that every study is conducted with scientific integrity, operational efficiency, and a patient-first approach.
TFS’s ophthalmology CRO expertise extends into rare ophthalmic diseases, advancing orphan drug development and innovative therapies for inherited retinal disorders and other rare ocular conditions.
As a leading ophthalmology contract research organization (CRO), TFS brings decades of experience in drug and device development, ensuring seamless execution across all trial phases. Our ophthalmology teams are highly specialized in managing complex imaging protocols, endpoint validation, and rare ophthalmic disorder studies. We ensure high-quality results through scientific precision, regulatory expertise, and innovative methodologies. Our track record of success in ophthalmology research reflects our commitment to advancing sight-saving therapies and improving patient outcomes worldwide.
See how we overcome obstacles to deliver results in ophthalmology research. Read our case study.
TFS is a trusted partner in ophthalmology clinical development, offering scientific expertise, global trial capabilities, and operational excellence to advance drug and device innovation. Our dedicated ophthalmology team supports sponsors in designing and executing complex clinical trials, leveraging adaptive trial frameworks, imaging biomarkers, and patient-centered strategies to enhance study precision and efficiency. With deep expertise in biologics, gene therapy, ophthalmic devices, and regenerative medicine, TFS ensures seamless navigation of regulatory pathways and global trial execution, accelerating the development of sight-saving therapies.
Explore the latest challenges and considerations in gene therapy for inherited retinal diseases (IRDs). Read our white paper.
TFS provides end-to-end support for ophthalmology clinical trials, ensuring accelerated enrollment and operational efficiency through our global site network and trusted investigator partnerships. Our expertise spans complex ophthalmic indications, demonstrating our commitment to advancing transformative therapies:
Age-Related Macular Degeneration (AMD) (Wet and Dry), Diabetic Retinopathy, Diabetic Macular Edema (DME) (a complication of Diabetic Retinopathy), Inherited Retinal Diseases (IRD), including Stargardt’s Disease and Retinitis Pigmentosa, and Geographic Atrophy (GA)
Dry Eye Disease (DED), Blepharoconjunctivitis, Keratoconjunctivitis, Corneal Cross-Linking for Keratoconus, and other corneal disorders
Primary Open-Angle Glaucoma, Ocular Hypertension, and Minimally Invasive Glaucoma Surgery (MIGS) devices, including MicroShunts, Cypass, Xen, and Tube Shunts
Intraocular Lenses (IOLs), Artificial Iris, Drug-Eluting Ophthalmic Devices, Lens Devices for Glaucoma, Corneal and Retinal Applications, and Surgical and Anesthesia Devices for Ophthalmology
Uveitis, Uveal Melanoma, and Optic Neuropathy
With our comprehensive capabilities and dedication to precision, TFS is the partner of choice for biotechnology sponsors seeking reliable support in ophthalmology clinical development.
Our ophthalmology leadership team brings decades of experience in ocular drug and device development, providing strategic oversight and hands-on expertise to navigate the complexities of ophthalmology clinical trials. With deep knowledge of specialized imaging, regulatory challenges, and patient recruitment, our experts ensure seamless execution across all phases of development. From retinal diseases and glaucoma therapies to anterior segment disorders and ophthalmic surgical innovations, we combine therapeutic expertise with operational excellence to drive efficient trial execution, precise endpoint assessments, and regulatory success.
TFS specializes in ophthalmology clinical trials, supporting sponsors in the development of novel therapies for retinal, anterior segment, and rare eye diseases. With expertise in biologics, gene therapy, medical devices, and regenerative medicine, we provide tailored solutions that address the complexities of ophthalmic drug and device development.
As a leading ophthalmology CRO, TFS ensures seamless execution of global ophthalmic trials through:
TFS has experience managing clinical trials for biologic treatments targeting retinal diseases, inflammatory conditions, and anterior segment disorders with expertise including:
Gene therapy is transforming inherited and acquired retinal diseases, and TFS provides specialized expertise in:
With ophthalmology is one of the most device-driven therapeutic areas, TFS offers expertise in:
The potential for stem cell therapies and tissue-engineered treatments in ophthalmology is expanding and TFS supports research in:
What makes TFS brings decades of experience in ophthalmology clinical research, supporting sponsors with specialized trial methodologies, advanced imaging capabilities, and global investigator networks. Our experts ensure seamless execution across all phases of drug and device development, delivering high-quality results efficiently.
TFS collaborates with leading reading centers and imaging specialists, providing high-resolution OCT, fluorescein angiography, fundus photography, and other advanced imaging solutions for ophthalmology studies.
We leverage AI-driven patient targeting, digital recruitment strategies, and an established ophthalmology site network to enhance trial enrollment and retention. Our extensive investigator relationships ensure access to diverse and specialized patient populations.
Our team has experience in ophthalmology gene therapy trials, supporting subretinal and intravitreal delivery techniques, patient recruitment, and regulatory compliance. We partner with sponsors to navigate the complexities of gene therapy in inherited retinal diseases and other vision-related conditions.
We employ real-time data monitoring, centralized data management, and ophthalmic imaging validation to maintain high data integrity and trial success. Our regulatory and safety teams work closely with sponsors to ensure compliance with evolving standards.
TFS regularly attends and presents at leading global ophthalmology conferences and events. You can connect with our team at upcoming meetings such as Euretina Congress, AAO, and ARVO.
These forums are excellent opportunities to meet our ophthalmology experts, explore partnership opportunities, and learn more about our commitment to advancing ophthalmology research worldwide.
Ready to advance ophthalmology research? Contact TFS today to explore how we can support your ophthalmology clinical trial needs with precision, expertise, and patient-centered solutions.
